SC 13G Filing

Company

Oruka Therapeutics, Inc.

Filed

November 14, 2005

Accession Number

0000895345-05-001086

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →